首页> 外国专利> Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

机译:糖皮质激素受体拮抗剂与糖皮质激素组合使用以治疗肾上腺素不足

摘要

This invention provides for a method of treating secondary adrenal insufficiency by co-administrating therapeutically effective amounts of a glucocorticoid and a glucocorticoid receptor antagonist to the patient in need thereof. In some embodiments, the method includes the proviso that the patient not be otherwise in need of treatment with a glucocorticoid and a glucocorticoid receptor antagonist. The treatment method can increase the patient's morning or basal cortisol level to at least about 12 μg/dL or a standard control level, and in turn, expedite significantly the recovery of the HPA axis. The method provided herein can improve health outcomes and life-threatening complications associated with secondary adrenal insufficiency.
机译:本发明提供了通过共同施用治疗有效量的糖皮质激素和有需要的患者治疗次要量的糖皮质激素和糖皮质激素受体拮抗剂来治疗二次肾上腺功能亢进的方法。 在一些实施方案中,该方法包括患者不需要用糖皮质激素和糖皮质激素受体拮抗剂治疗的附带。 处理方法可以将患者的早晨或基础皮质醇水平增加至至少约12μg/ dL或标准控制水平,然后又加速HPA轴的恢复。 本文提供的方法可以改善与继发肾上腺功能不全相关的健康结果和危及生命的并发症。

著录项

  • 公开/公告号US11202784B2

    专利类型

  • 公开/公告日2021-12-21

    原文格式PDF

  • 申请/专利权人 CORCEPT THERAPEUTICS INC.;

    申请/专利号US202016816014

  • 申请日2020-03-11

  • 分类号A61K31/44;A61K31/56;A61K31/567;A61K31/575;A61K31/513;A61K31/473;A61K31/437;

  • 国家 US

  • 入库时间 2022-08-24 22:56:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号